Chronic L-deprenyl treatment alters brain monoamine levels and reduces impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder

被引:52
作者
Boix, F [1 ]
Qiao, SW [1 ]
Kolpus, T [1 ]
Sagvolden, T [1 ]
机构
[1] Univ Oslo, Dept Neurophysiol, Oslo, Norway
关键词
impulsiveness; hyperactivity; SHR; AD/HD; MAO; L-deprenyl; 5-HT; dopamine; noradrenaline; monoamines; neostriatum; nucleus accumbens; frontal cortex;
D O I
10.1016/S0166-4328(97)00176-9
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Effects of chronic L-deprenyl administration on hyperactive behaviour and brain monoamine levels were studied in spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats. SHR were hyperactive, impulsive and had impaired sustained attention when tested with a multiple 2-min fixed interval (FI) 5-min extinction (EXT) schedule of reinforcement. Even low, 0.25 mg/kg, doses of chronically-administered L-deprenyl reduced the impulsiveness (bursts of responses with short interresponse times) of SHR, without altering the general hyperactivity or the impaired sustained attention. The drug had no effect on WKY behaviour. The levels of noradrenaline (NA), dopamine (DA), serotonin (5-hydroxytryptamine, 5-HT) and their metabolites, measured in neostriatum, nucleus accumbens and frontal cortex, showed that L-deprenyl effectively inhibited monoamine oxidase (MAO) activity. These results suggest that impulsiveness is a behavioural component that may be operating independent of the other components, like hyperactivity and deficient sustained attention, and that can be reduced by chronic MAO-B inhibition with L-deprenyl in this strain of rats. The positive effect of L-deprenyl on impulsiveness is discussed as due either to normalization of an asymmetric dopaminergic activity in the nucleus accumbens, or to a restoration of normal DA function in the prefrontal cortex. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:153 / 162
页数:10
相关论文
共 48 条
  • [1] *AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P78
  • [2] Sex differences in operant discrimination behaviour in an animal model of attention-deficit hyperactivity disorder
    Berger, DF
    Sagvolden, T
    [J]. BEHAVIOURAL BRAIN RESEARCH, 1998, 94 (01) : 73 - 82
  • [3] THE FUNCTIONAL-ROLE OF MONOAMINE OXIDASE-A AND OXIDASE-B IN THE MAMMALIAN CENTRAL-NERVOUS-SYSTEM
    BERRY, MD
    JUORIO, AV
    PATERSON, IA
    [J]. PROGRESS IN NEUROBIOLOGY, 1994, 42 (03) : 375 - 391
  • [4] Differential distribution, affinity and plasticity of dopamine D-1 and D-2 receptors in the target sites of the mesolimbic system in an animal model of ADHD
    Carey, MP
    Diewald, LM
    Esposito, FJ
    Pellicano, MP
    Carnevale, UAG
    Sergeant, JA
    Papa, M
    Sadile, AG
    [J]. BEHAVIOURAL BRAIN RESEARCH, 1998, 94 (01) : 173 - 185
  • [5] IV PENTAZOCINE/METHYLPHENIDATE ABUSE - THE CLINICAL TOXICITY OF ANOTHER TS AND BLUES COMBINATION
    CARTER, HS
    WATSON, WA
    [J]. JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1994, 32 (05): : 541 - 547
  • [6] Cesura A M, 1992, Prog Drug Res, V38, P171
  • [7] COLZI A, 1990, J NEUR TR S, P79
  • [8] ALPHA(2)-ADRENOCEPTOR MEDIATED INHIBITION OF [H-3] DOPAMINE RELEASE FROM NUCLEUS-ACCUMBENS SLICES AND MONOAMINE LEVELS IN A RAT MODEL FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    DEVILLIERS, AS
    RUSSELL, VA
    SAGVOLDEN, T
    SEARSON, A
    JAFFER, A
    TALJAARD, JJF
    [J]. NEUROCHEMICAL RESEARCH, 1995, 20 (04) : 427 - 433
  • [9] Douglas V.I., 1983, DEV NEUROPSYCHIATRY, P280
  • [10] METHYLPHENIDATE AND DEXTROAMPHETAMINE TREATMENTS OF HYPERACTIVITY - ARE THERE TRUE NONRESPONDERS
    ELIA, J
    BORCHERDING, BG
    RAPOPORT, JL
    KEYSOR, CS
    [J]. PSYCHIATRY RESEARCH, 1991, 36 (02) : 141 - 155